Analysis and Commentary 7/8/16 Analysis and Commentary 7/8/16 Little Good News is Bad News Read More Analysis and Commentary 6/25/16 Analysis and Commentary 6/25/16 Time to Face Up to the Future Read More Analysis and Commentary 6/17/16 Analysis and Commentary 6/17/16 Let's Praise FDA for What is Going Well! Read More Analysis and Commentary 6/10/16 Analysis and Commentary 6/10/16 A Reason for Hope Read More Analysis and Commentary 6/3/16 Analysis and Commentary 6/3/16 Let's Get the Ag/FDA Appropriations Bill into Law Read More Analysis and Commentary 5/20/16 Analysis and Commentary 5/20/16 A Slight Improvement -- But Not Enough! Read More Analysis and Commentary 5/13/16 Analysis and Commentary 5/13/16 Guarded Optimism -- With No Crystal Ball Read More Analysis and Commentary 5/9/16 Analysis and Commentary 5/9/16 A Well Illuminated Process of Decision-Making Read More Analysis and Commentary 4/30/16 Analysis and Commentary 4/30/16 Broadening Knowledge About FDA on Capitol Hill Read More Analysis and Commentary 4/22/16 Analysis and Commentary 4/22/16 The Start of the Califf Era Read More Analysis and Commentary 4/15/16 Analysis and Commentary 4/15/16 Give Us Something We Can Support! Read More Analysis and Commentary 4/8/16 Analysis and Commentary 4/8/16 The Impracticalities of Uneconomics Read More Analysis and Commentary 4/1/16 Analysis and Commentary 4/1/16 It Costs Money to Wag the Tail of the Dog! Read More Analysis and Commentary 3/26/16 Analysis and Commentary 3/26/16 FDA-Related Legislation and Budgetary Implications Read More Analysis and Commentary 3/19/16 Analysis and Commentary 3/19/16 Alliance Overcomes Shutdown (of DC Metro System) Read More Analysis and Commentary 3/12/16 Analysis and Commentary 3/12/16 Four Key Points for Hill Day 2016 Read More Analysis and Commentary 3/4/16 Analysis and Commentary 3/4/16 Califf Debuts on Capitol Hill with Two Priorities Read More Analysis and Commentary 2/27/16 Analysis and Commentary 2/27/16 "Everything is a high priority" for the FDA today Read More Analysis and Commentary 2/19/16 Analysis and Commentary 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More Analysis and Commentary 2/12/16 Analysis and Commentary 2/12/16 Of Smoke, Mirrors, and Advocacy Participation Read More Newer Posts Older Posts
Analysis and Commentary 6/25/16 Analysis and Commentary 6/25/16 Time to Face Up to the Future Read More
Analysis and Commentary 6/17/16 Analysis and Commentary 6/17/16 Let's Praise FDA for What is Going Well! Read More
Analysis and Commentary 6/3/16 Analysis and Commentary 6/3/16 Let's Get the Ag/FDA Appropriations Bill into Law Read More
Analysis and Commentary 5/20/16 Analysis and Commentary 5/20/16 A Slight Improvement -- But Not Enough! Read More
Analysis and Commentary 5/13/16 Analysis and Commentary 5/13/16 Guarded Optimism -- With No Crystal Ball Read More
Analysis and Commentary 5/9/16 Analysis and Commentary 5/9/16 A Well Illuminated Process of Decision-Making Read More
Analysis and Commentary 4/30/16 Analysis and Commentary 4/30/16 Broadening Knowledge About FDA on Capitol Hill Read More
Analysis and Commentary 4/22/16 Analysis and Commentary 4/22/16 The Start of the Califf Era Read More
Analysis and Commentary 4/15/16 Analysis and Commentary 4/15/16 Give Us Something We Can Support! Read More
Analysis and Commentary 4/8/16 Analysis and Commentary 4/8/16 The Impracticalities of Uneconomics Read More
Analysis and Commentary 4/1/16 Analysis and Commentary 4/1/16 It Costs Money to Wag the Tail of the Dog! Read More
Analysis and Commentary 3/26/16 Analysis and Commentary 3/26/16 FDA-Related Legislation and Budgetary Implications Read More
Analysis and Commentary 3/19/16 Analysis and Commentary 3/19/16 Alliance Overcomes Shutdown (of DC Metro System) Read More
Analysis and Commentary 3/12/16 Analysis and Commentary 3/12/16 Four Key Points for Hill Day 2016 Read More
Analysis and Commentary 3/4/16 Analysis and Commentary 3/4/16 Califf Debuts on Capitol Hill with Two Priorities Read More
Analysis and Commentary 2/27/16 Analysis and Commentary 2/27/16 "Everything is a high priority" for the FDA today Read More
Analysis and Commentary 2/19/16 Analysis and Commentary 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More
Analysis and Commentary 2/12/16 Analysis and Commentary 2/12/16 Of Smoke, Mirrors, and Advocacy Participation Read More
